Skip to main content
OpenTrials

Clinical trial condition

High Risk for Febrile Neutropenia of Chemotherapy Regimens

Explore clinical trials studying High Risk for Febrile Neutropenia of Chemotherapy Regimens. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

High Risk for Febrile Neutropenia of Chemotherapy Regimens trial results

Recruiting

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

NCT07187908

Conditions
High Risk for Febrile Neutropenia of Chemotherapy Regimens, Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia, Primary/Secondary Prevention
Locations
  • The Henan cancer hospital Zhengzhou, Henan, China
View Trial Details

Related conditions